Associated Papers
In Silico Analysis of PORD Mutations on the 3D Structure of P450 Oxidoreductase.
Nurhafizuddin M et al.
Molecules (basel, Switzerland), 2022
Polymorphisms in cytochrome P450 oxidoreductase and its effect on drug metabolism and efficacy.
Gong L et al.
Pharmacogenetics and Genomics, 2017
P450 Oxidoreductase deficiency: Analysis of mutations and polymorphisms.
Burkhard FZ et al.
The Journal of Steroid Biochemistry and Molecular Biology, 2017
Pharmacogenomics of human P450 oxidoreductase.
Pandey AV et al.
Frontiers in Pharmacology, 2014
Altered human CYP3A4 activity caused by Antley-Bixler syndrome-related variants of NADPH-cytochrome P450 oxidoreductase measured in a robust in vitro system.
Moutinho D et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals, 2012
Identification of six novel P450 oxidoreductase missense variants in Ashkenazi and Moroccan Jewish populations.
Tomková M et al.
Pharmacogenomics, 2012
Deletion of P399_E401 in NADPH cytochrome P450 oxidoreductase results in partial mixed oxidase deficiency.
Flück CE et al.
Biochemical and Biophysical Research Communications, 2011
Mutations of human cytochrome P450 reductase differentially modulate heme oxygenase-1 activity and oligomerization.
Marohnic CC et al.
Archives of Biochemistry and Biophysics, 2011
Clinical and biochemical consequences of p450 oxidoreductase deficiency.
Flück CE et al.
Endocrine Development, 2011
Genetic variation in human P450 oxidoreductase.
Miller WL et al.
Molecular and Cellular Endocrinology, 2009
Pharmacogenetics of P450 oxidoreductase: effect of sequence variants on activities of CYP1A2 and CYP2C19.
Agrawal V et al.
Pharmacogenetics and Genomics, 2008
P450 oxidoreductase: genetic polymorphisms and implications for drug metabolism and toxicity.
Hart SN et al.
Expert Opinion on Drug Metabolism & Toxicology, 2008
Genetic polymorphisms in cytochrome P450 oxidoreductase influence microsomal P450-catalyzed drug metabolism.
Hart SN et al.
Pharmacogenetics and Genomics, 2008
Genetic and clinical features of p450 oxidoreductase deficiency.
Scott RR et al.
Hormone Research, 2008
P450 oxidoreductase deficiency - a new form of congenital adrenal hyperplasia.
Flück CE et al.
Endocrine Development, 2008
Clinical, structural and functional implications of mutations and polymorphisms in human NADPH P450 oxidoreductase.
Flück CE et al.
Fundamental & Clinical Pharmacology, 2007
Diminished FAD binding in the Y459H and V492E Antley-Bixler syndrome mutants of human cytochrome P450 reductase.
Marohnic CC et al.
The Journal of Biological Chemistry, 2006
Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis.
Huang N et al.
American Journal of Human Genetics, 2005